Effects of Prenatal Alcohol Exposure on Emotional and Cognitive Abilities in Adults
NCT ID: NCT03793920
Last Updated: 2022-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
144 participants
INTERVENTIONAL
2018-11-08
2022-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors).
Primary objective:
To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Effects of Alcohol
NCT05826951
FGF21 and Its Role in Alcohol Dependence
NCT03892369
Genetics of the Acute Response to Alcohol in Social Drinkers
NCT01375556
Effect of Moderate Alcohol Consumption on Postprandial Mood
NCT01426022
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
NCT04557631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First visit :
* Checking inclusion and non-inclusion criteria
* Note of information and consent form
* Record of concomitant treatments and anamnestic elements
* Alcohol, Tobacco, and Toxic Consumption
* Urinary Toxicity Test for Control Groups
* Laterality test (Hecaen, 1984)
* Brief visual and auditory acuity test
* Standardized psychiatric interview (Mini International Neuropsychiatric Interview - MINI)
Second visit = Experimental testing
* State-Trait Anxiety Inventory, Beck Depression Inventory, Inventory of Interpersonal Problems, Toronto Alexithymia Scale (TAS-20).
* Participant installation and testing: 6 behavioral tasks on a computer (also used to collect responses, except for task 2, see details below) :
Task 1 (MAIN): Test for recognition of facial emotions Task 2: 'Reading the Mind in the Eyes Test' (Decoding of complex emotional states) Task 3: Emotional evaluation of natural scenes Task 4: Target detection (measure of attentional bias towards alcohol-related stimuli) Task 5: Go / No-Go evaluating the interactions between inhibition processes and auto-affective system Task 6: "N-back" evaluating the interactions between working memory and automatic-affective system
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PEA patients without alcohol disorder
A group of 36 PEA patient without alcohol-dependence (AD), performing 6 behavioral tasks.
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
PEA patients with alcohol disorder
A group of 36 PEA participants, currently alcohol-dependent, performing 6 behavioral tasks.
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
Healthy controls with AD father
A group of 36 non-alcohol-dependent controls whose father was alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
Healthy controls without AD father
A group of 36 non-alcohol-dependent controls whose father was not alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand and to speak French
* Able to understand Note of information and to sign consent form
* Available health insurance
* Normal (or corrected to normal) vision and audition
* For women: Negative pregnancy test or menopausal for at least one year
* For Group 1 only : PEA criteria and no alcohol consumption within the three days preceding the experiment.
* For Group 2 only : PEA criteria, diagnosed with severe alcohol addiction and currently abstinent (for at least 15 days).
* For Group 3 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment and father diagnosed with severe alcohol addiction.
* For Group 4 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment.
Exclusion Criteria
* Visual or auditory sensory disability to participate in the study.
* Benzodiazepines and / or Antipsychotic concomitant treatment.
* History of (or current) neurologic disease
* History of (or current) psychiatric disorder (apart alcohol-dependence for the PEA-alcohol-dependent group)
* Psychoactive Substance Use or Abuse other than tobacco and alcohol.
* Pregnant or breast-feeding women.
* Underage (\<18 yo) or adults under guardianship, judicial protection, or deprived of liberty.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier COTTENCIN, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSAPA
Lille, , France
CHRU Lille, Fontan2
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00843-50
Identifier Type: OTHER
Identifier Source: secondary_id
2015_76
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.